SRPT - Sarepta Therapeutics Inc
IEX Last Trade
135.75
-1.500 -1.105%
Share volume: 770,344
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$137.25
-1.50
-1.09%
Summary score
28%
Profitability
18%
Dept financing
20%
Liquidity
70%
Performance
31%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-21.07%
Return on assets
-3.52%
Return on sales
-56.89%
Return on invested capital
-48.25%
Total debt ratio
76.01%
Debt ratio change over timeo
-1.56%
Current Ratio
5.24%
Quick Ratio
4.73%
Cash Position Ratio
3.97%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0.12%
Return on assets
-0.78%
Return on sales
-10.69%
Return on invested capital
33.33%
Total debt ratio
73.89%
Debt ratio change over timeo
-2.3%
Current Ratio
4.6%
Quick Ratio
4.07%
Cash Position Ratio
3.11%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
3.76%
Return on assets
1.08%
Return on sales
8.44%
Return on invested capital
23.95%
Total debt ratio
70.19%
Debt ratio change over time
-0.51%
Current Ratio
4.05%
Quick Ratio
3.44%
Cash Position Ratio
2.28%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-91.86%
Return on assets
-96.86%
Return on sales
-58.68%
Return on invested capital
14.54%
Total debt ratio
-155.81%
Debt ratio change over time
-1.56%
Current Ratio
-5.4%
Quick Ratio
-5%
Cash Position Ratio
-4.4%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SRPT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -21.07% | 13.79% | 34.47% | 7.43% |
| Return on assets | -3.52% | 2.76% | 3.15% | 5.62% |
| Return on sales | -56.89% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -48.25% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 76.01% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.56% | 308.97% | -6.99% | 1.18% |
| Dept financing | 21% | 50% | 25% | 7% |
| Current Ratio | 4.6% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 4.07% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.11% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 10% | 23% | 54% |
| Short-term ratios | SRPT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 0.12% | 13.77% | 13.25% | 3.8% |
| Return on assets | -0.78% | 2.43% | 1.89% | 3.09% |
| Return on sales | -10.69% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 33.33% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 66% | 61% | 64% |
| Total debt ratio | 73.89% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -2.3% | 46.38% | -72.08% | 1.51% |
| Dept financing | 20% | 50% | 25% | 7% |
| Current Ratio | 4.6% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 4.07% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.11% | 0.36% | 1.28% | 2.93% |
| Liquididy | 68% | 11% | 30% | 74% |